By Emma Foster on Wed 09 November 2022

Recombinant DNA (rDNA) technology has enabled the new generation of bioproducts, including antibodies, growth factors, fusion proteins, vaccines, and growth factors, conceivable. Learn more about bioprocessing and biotechnology in the pharmaceutical industry.